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Summary and Implications 
 We evaluated the effect of Bovamine ( Lactobacillus 
acidophilus strain NP51 and Probionibacterium 
freudenreichii strain NP24) feeding on the digestive system 
microbiome of dairy cattle during late lactation (average 
DIM = 202). To unveil the underlying mechanisms, we 
examined Bovamine
 
effects on ruminal total volatile fatty 
acid (VFA) concentration and the Firmicutes : Bacteroides. 
Dairy cows were randomized to treatment groups that were 
either fed the Bovamine or the lactose carrier top-dressed on 
the total mixed ration (TMR) for six weeks.  Feeding 
Bovamine favorably modified the digestive system 
microbiome as determined by the bacterial tag encoded FLX 
amplicon pyrosequencing (bTEFAP). Fecal Firmicutes : 
Bacteroides was decreased, suggesting decreased shedding 
of potential pathogens. Conversly, ruminal Firmicutes : 
Bacteroides was increased  indicating increased energy 
harvest. As a result, concentrations of the total VFA were 
increased significantly in the rumen. Also, natural killer 
cells (NK) frequency was increased under stimulation with 
mitogen concanavalin (ConA) in vitro, suggesting improved 
cattle immunity. Results advocate that feeding Bovamine to 
lactating dairy cows favorably alters their digestive system 
microbiome,  improves the dietary energy availability, and 
health of cattle with significant implications to transition 
and early lactation dairy cows. A future study will be 
conducted to determine possible improvement in feed 
efficiency of mid-lactation dairy cows. 
 
Introduction 
 Bovamine is a probiotic formulation that contains 
probiotic Lactobacillus acidophilus strain NP51, a lactic 
acid producer, and probiotic Probionibacterium 
freudenreichii, a lactic acid utilizer. These Bovamine 
metabolic properties allow the feeding concentrates to high 
producing dairy cows to increase milk production. It has 
been established that Lactobacillus acidophilus strain NP51 
favorably modifies the immune responses of dairy cows and 
of a mouse model of Johne’s disease.  Thus, the use of 
Bovamine to improve ruminal fermentation and enhance 
immunity of dairy cows is a research objective to improve 
overall productivity and health, and thus profitability of 
dairy cattle.  
 
Materials and Methods 
Dairy cows (24 Holsteins and 24 Jerseys; average DIM 
= 202 days) were assigned randomly to one of two treatment 
groups: Bovamine (n = 24) or control (n = 24).  Each 
treatment group contained 12 Holstein and 12 Jersey cows 
housed separately. Following an adaptation period, the 
Bovamine group was fed the Bovamine probiotic mixture at 
1 ×10
9
 CFU of Lactobacillus acidophilus strain NP51 plus 2 
× 10
9
 CFU of Probionibacterium freudenreichii ∙ cow-1∙day-
1 
for six weeks. The Bovamine dose was blended with 1.04 
g of lactose carrier that was mixed with 472 g of ground 
corn and top-dressed on the TMR fed ad libitum. Similarly, 
the control group was fed the lactose carrier at 1.04 g∙cows-
1∙day-1. On wk 3 and wk 6 relative to Bovamine feeding, 
ruminal (100 mL) and fecal (15 g) samples were collected 
and used for examination of ruminal and fecal microbiota. 
Additionally, part of the ruminal samples was used to 
determine the concentrations of FVA. 
 
Results and Discussion 
 Feeding Bovamine to late lactation dairy cows modified 
significantly the concentrations of ruminal VFA. By wk 3, 
Bovamine feeding substantially increased (P = 0.0001; 
Table 1) total VFA by 34% compared with those of the 
control dairy cows. Also, by the end of wk 6, Bovamine 
feeding significantly (P = 0.005) increased total VFAs by 
32.5% to be greater than that of the control dairy cows 
(Tabel 1).  Elucidation of the microbiomic mechanism via 
which Bovamine increases ruminal VFA cocentration 
showed that  Bovamine feeding  tended (P= 0.06) to 
increase ruminal Firmicutes : Bacteroides (Figure 1). As a 
result, the energy capture was enhanced because VFA 
concentration increased (Figure 1). Also, Bovamine feeding 
increased NK cells in peripheral blood when stimulated with 
ConA (Table 2) implying improved cows immunity and 
health. These data  indicate that Bovamine feeding to dairy 
cows advantageously modifies the ruminal microbiome to 
enhance cows immunity and increase the dietary energy 
capture with significant implications for transition and early 
lactation dairy cows. 
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Table 1. Effects of Bovamine feeding to dairy cattle on ruminal total VFA production at time 0, wk 3, and wk 6 
relative to Bovamine feeding. Data are mean ± SEM. (SEM = 6.03-8.44). 
 
 
Total VFA, mM  
Time Control Bovamine-fed Statistics (P value) 
Time 0 69.7 ± 4.9 64.8 ± 5.4 0.50 
Wk 3 81.7 ± 4.5 109.1 ± 4.4 0.0001 
Wk 6 56.0 ± 4.6 74.2 ± 4.4 0.005 
 
Bovamine, (Lactobacillus acidophilus strain NP51 and Probionibacterium freudenreichii strain NP24).
 
 
 
 
 
 
Figure 1. Effects of Bovamine feeding to dairy cattel on the ratio of the relative abundance of Firmicutes to 
Bacteroides (F/B) in rumen. Points represent individual observations, and subjects are linked with a line. Average 
changes are denoted by the black lines. (C) stands for control and (P) stands for probiotic Bovamine. 
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Table 2. Effects of Bovamine feeding to dairy cattel on CD335
+
 NK cell repertoire in PMNs on  
time 0, wk 3, and wk 6 relative to Bovamine feeding. Data are mean ± SEM. (SEM = 0.11-0.13). 
 
CD335
+
 NK cells repertoire frequency  
Time Stimulation Control Bovamine-fed Statistics (P value) 
Time 0 NS 1.7  ± 0.08 1.7 ± 0.10 0.99 
 ConA 2.5 ± 0.08 2.6 ± 0.1 0.33 
Wk 3 NS 1.7 ± 0.07 1.6 ± 0.08 0.79 
 ConA 2.5 ± 0.07 3.5 ± 0.08 0.0001 
Wk 6 NS 1.9 ± 0.08 1.8 ± 0.08 0.73 
 ConA 2.6 ± 0.08 3.9 ± 0.08 0.0001 
 
                                                                                                                                                                                                 
Stimulation: stimulation with concanavalin A (ConA) or no stimulation (NS); NK, cell, natural killer cells. Bovamine, 
(Lactobacillus acidophilus strain NP51 and Probionibacterium freudenreichii strain NP24) 
 
 
